Clinical applications of immunoglobulin free light chain estimations.
The relevance of free light chain assays to diagnosis, staging, treatment and prognosis assessment in B-cell disorders (including myeloma, chronic lymphocytic leukaemia, and lymphoma), multiple sclerosis and diabetes is discussed and their actual and potential use is examined.
Tillyer
C R
CR
Department of Chemical Pathology, Royal Marsden Hospital, London, UK.
D003920:Diabetes Mellitus / Q000276:immunology*; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000032:analysis*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology*; D008223:Lymphoma / Q000276:immunology*; D009103:Multiple Sclerosis / Q000276:immunology*
D007147:Immunoglobulin Light Chains